ATE442136T1 - Verfahren zur herstellung einer zusammensetzung mit venlafaxin mit programmierter freisetzung und das resultierende produkt - Google Patents
Verfahren zur herstellung einer zusammensetzung mit venlafaxin mit programmierter freisetzung und das resultierende produktInfo
- Publication number
- ATE442136T1 ATE442136T1 AT02715321T AT02715321T ATE442136T1 AT E442136 T1 ATE442136 T1 AT E442136T1 AT 02715321 T AT02715321 T AT 02715321T AT 02715321 T AT02715321 T AT 02715321T AT E442136 T1 ATE442136 T1 AT E442136T1
- Authority
- AT
- Austria
- Prior art keywords
- phase
- resulting product
- venlafaxine
- preparing
- active
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 3
- PNVNVHUZROJLTJ-UHFFFAOYSA-N venlafaxine Chemical group C1=CC(OC)=CC=C1C(CN(C)C)C1(O)CCCCC1 PNVNVHUZROJLTJ-UHFFFAOYSA-N 0.000 title abstract 2
- 229960004688 venlafaxine Drugs 0.000 title abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- 229940079593 drug Drugs 0.000 abstract 2
- 239000008187 granular material Substances 0.000 abstract 2
- 238000002360 preparation method Methods 0.000 abstract 2
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 abstract 1
- 229920002472 Starch Polymers 0.000 abstract 1
- 238000010521 absorption reaction Methods 0.000 abstract 1
- 230000002411 adverse Effects 0.000 abstract 1
- 230000001476 alcoholic effect Effects 0.000 abstract 1
- 239000011248 coating agent Substances 0.000 abstract 1
- 238000000576 coating method Methods 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 238000005538 encapsulation Methods 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 239000004531 microgranule Substances 0.000 abstract 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 abstract 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 abstract 1
- 229940069328 povidone Drugs 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
- 235000019698 starch Nutrition 0.000 abstract 1
- 239000008107 starch Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Neurosurgery (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
- Compounds Of Unknown Constitution (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| BR0100334-8A BR0100334A (pt) | 2001-01-17 | 2001-01-17 | Processo para a preparação de composições de liberação programada contendo venlafaxina e o produto resultante |
| PCT/BR2002/000001 WO2002102129A2 (en) | 2001-01-17 | 2002-01-03 | Process for the preparation of programmed liberation compositions with venlafaxine and the resulting product |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE442136T1 true ATE442136T1 (de) | 2009-09-15 |
Family
ID=37734022
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02715321T ATE442136T1 (de) | 2001-01-17 | 2002-01-03 | Verfahren zur herstellung einer zusammensetzung mit venlafaxin mit programmierter freisetzung und das resultierende produkt |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US7563456B2 (de) |
| EP (1) | EP1578342B1 (de) |
| AT (1) | ATE442136T1 (de) |
| AU (1) | AU2002224680A1 (de) |
| BR (1) | BR0100334A (de) |
| CY (1) | CY1109535T1 (de) |
| DE (1) | DE60233685D1 (de) |
| DK (1) | DK1578342T3 (de) |
| ES (1) | ES2333302T3 (de) |
| MX (1) | MXPA03003530A (de) |
| PT (1) | PT1578342E (de) |
| WO (1) | WO2002102129A2 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR0100334A (pt) * | 2001-01-17 | 2002-09-24 | Diffucap Chemobras Quimica E F | Processo para a preparação de composições de liberação programada contendo venlafaxina e o produto resultante |
| IL146462A (en) | 2001-11-13 | 2015-02-26 | Lycored Bio Ltd | Prolonged-release preparations containing as an active compound and analapaxin hydrochloride |
| US20030191347A1 (en) * | 2002-03-28 | 2003-10-09 | Rolf Keltjens | Venlafaxine base |
| AU2003219184A1 (en) * | 2002-05-09 | 2003-11-11 | Diffucap-Chemobras Quimica E Farmaceutica, Ltda. | Novel method of preparing programmed-release compositions containing (s)-1-(n-(1-(ethoxycarbonyl)-3-phenylpropyl)-l-alanyl)-l-proline and the product thus obtained |
| AU2003278549A1 (en) * | 2002-11-28 | 2004-06-18 | Themis Laboratories Private Limited | Process for manufacturing sustained release microbeads containing venlafaxine hci |
| ATE336988T1 (de) | 2003-07-30 | 2006-09-15 | Pharmathen Sa | Venlafaxine hydrochloridformulierungen mit verzögerter freisetzung |
| WO2007102169A1 (en) * | 2006-03-08 | 2007-09-13 | Jubilant Organosys Limited | Extended release pharmaceutical formulation of venlafaxine and method of manufacturing the same |
| US20070248669A1 (en) * | 2006-04-25 | 2007-10-25 | Fang-Hsiung Hsiao | Oral sustained release formulation |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1509866A (en) * | 1975-06-10 | 1978-05-04 | Johnson & Johnson | Enteric coated digestive enzyme compositions |
| DE3382392D1 (de) * | 1982-07-09 | 1991-10-02 | Key Pharma | Dosierungsart zur dauerhaften verabreichung von chinidin. |
| US6001848A (en) * | 1996-03-25 | 1999-12-14 | The Regents Of The University Of California | Bromocriptine for the treatment of alcoholics diagnosed with the D2 dopamine receptor DRD2 A1 allele |
| EP1178780B1 (de) * | 1999-05-20 | 2007-07-18 | ELAN CORPORATION, Plc | Multipartikuläre arzneizusammensetzungen mit gesteuerter wirkstoffabgabe enthaltend selektive inhibitoren der serotoninwiederaufnahme |
| BR0100334A (pt) * | 2001-01-17 | 2002-09-24 | Diffucap Chemobras Quimica E F | Processo para a preparação de composições de liberação programada contendo venlafaxina e o produto resultante |
-
2001
- 2001-01-17 BR BR0100334-8A patent/BR0100334A/pt not_active Application Discontinuation
-
2002
- 2002-01-03 EP EP02715321A patent/EP1578342B1/de not_active Expired - Lifetime
- 2002-01-03 AU AU2002224680A patent/AU2002224680A1/en not_active Abandoned
- 2002-01-03 MX MXPA03003530A patent/MXPA03003530A/es active IP Right Grant
- 2002-01-03 DE DE60233685T patent/DE60233685D1/de not_active Expired - Lifetime
- 2002-01-03 PT PT02715321T patent/PT1578342E/pt unknown
- 2002-01-03 AT AT02715321T patent/ATE442136T1/de active IP Right Revival
- 2002-01-03 US US10/476,714 patent/US7563456B2/en not_active Expired - Lifetime
- 2002-01-03 DK DK02715321.2T patent/DK1578342T3/da active
- 2002-01-03 ES ES02715321T patent/ES2333302T3/es not_active Expired - Lifetime
- 2002-01-03 WO PCT/BR2002/000001 patent/WO2002102129A2/en not_active Ceased
-
2009
- 2009-12-01 CY CY20091101265T patent/CY1109535T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MXPA03003530A (es) | 2005-01-25 |
| EP1578342B1 (de) | 2009-09-09 |
| WO2002102129A2 (en) | 2002-12-27 |
| US7563456B2 (en) | 2009-07-21 |
| WO2002102129A3 (en) | 2006-12-07 |
| AU2002224680A1 (en) | 2003-01-02 |
| DE60233685D1 (de) | 2009-10-22 |
| PT1578342E (pt) | 2009-12-15 |
| EP1578342A2 (de) | 2005-09-28 |
| AU2002224680A8 (en) | 2007-02-01 |
| DK1578342T3 (da) | 2010-01-18 |
| US20040131677A1 (en) | 2004-07-08 |
| ES2333302T3 (es) | 2010-02-19 |
| CY1109535T1 (el) | 2014-08-13 |
| BR0100334A (pt) | 2002-09-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1109535T1 (el) | Μεθοδος για παρασκευη συνθεσης προγραμματισμενης απελευθερωσης με βενλαφαξινη και το προκυπτον προϊον | |
| MY139427A (en) | Controlled-release pharmaceutical composition and method for producing the same | |
| DE602005021372D1 (de) | Zusammensetzung in mikropellets mit kontrollierter freisetzung von physiologischen wirksubstanzen, verfahren zu ihrer herstellung und ihre verwendung im zootechnischen sektor | |
| PT1204699E (pt) | Composicoes para peliculas a base de pululano | |
| BR9915087A (pt) | Formulação farmacêutica oral revestida entérica, uso de uma qualidade de hidroxipropil celulose (hpc), processo para a munufatura de uma formulação farmacêutica oral revestida entérica, uso de uma formulação farmacêutica, e, método para o tratamento de doenças gastrointestinais em mamìferos, incluindo o homem | |
| WO2007054976A3 (en) | Lipid based controlled release pharmaceutical composition | |
| ATE386017T1 (de) | Carbonsäureamid substituierte phenylharnstoffderivate, verfahren zu ihrer herstellung als arzneimittel | |
| WO2009154777A3 (en) | Process for preparing and drying solid rasagiline base | |
| CA2481848A1 (en) | Active ingredient particles carrying clopidogrel or a salt thereof, their use and method of preparation | |
| WO2006125620A3 (en) | Cores and microcapsules suitable for parenteral administration as well as process for their manufacture | |
| WO2005117843A3 (en) | Sustained release preparations | |
| FI914354A0 (fi) | Menetelmä säädellysti lääkeainetta vapauttavan valmisteen valmistamiseksi | |
| DE60211769D1 (de) | Verfahren zur Herstellung von Arzneistoffgranulatkörnern, die Arzneistoffgranulatkörner sowie diese enthaltende pharmazeutische Zubereitungen | |
| WO2008138348A8 (en) | Preparation of complexed lactalbumin | |
| WO2007020259A3 (en) | Controlled release pharmaceutical compositions for acid labile drugs | |
| WO2003057150A3 (en) | A stable pharmaceutical formulation of paroxetine hydrochloride and a process for preparation thereof | |
| NO20064934L (no) | Fremgangsmate for fremstilling av et fast, farmasoytisk preparat | |
| WO2006130703A3 (en) | Modified release formulations of anti-irritability drugs | |
| HUP0102027A2 (hu) | Késleltetett és időzített hatóanyag-felszabadulást biztosító multipartikuláris gyógyszerforma és előállítási eljárása | |
| DE60100500D1 (de) | Suspension enthaltend ein epi-hne protein, verfahren zu ihrer herstellung, daraus hergestelltes trockenpulveraerosol, arzneimittelzusammensetzungen enthaltend diese suspension oder dieses aerosol und ihre verwendungen | |
| DE60322763D1 (de) | Verfahren zur Herstellung eines Pulvers mit hohem Gerbstoffgehalt | |
| WO2008029351A3 (en) | A modified release formulation comprising amoxicillin and clavulanate | |
| WO2004026261A3 (en) | Composition containing ribavirin and use thereof | |
| WO2005065647A3 (en) | Drug granule coatings that impart smear resistance during mechanical compression | |
| WO2007073894A3 (de) | Orales präparat mit kontrollierter freisetzung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties | ||
| EEWE | Authorization for restitution |